Status:
TERMINATED
Inheritance of Osteosarcoma & Paget's Disease Through Chromosome 18:
Lead Sponsor:
State University of New York - Upstate Medical University
Conditions:
Osteosarcoma
Paget's Disease
Eligibility:
All Genders
Brief Summary
Researchers have previously demonstrated loss of heterozygosity in a region on chromosome 18q, associated with osteogenic sarcomas in bone affected by Paget's disease. The loci used in this study are ...
Detailed Description
As above, no additional information
Eligibility Criteria
Inclusion
- This is a familial study therefore the only inclusion/exclusion criteria would be that subjects must be a blood relative and over the age of 18.
- The subjects are proband and father along with unaffected blood relatives. Their peripheral blood will act as a control and provide information to delineate the inheritance from the father, as seen in the son.
Exclusion
- Not part of the family
Key Trial Info
Start Date :
April 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT00615628
Start Date
April 1 2002
End Date
December 1 2009
Last Update
May 30 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SUNY Upstate Medical University
Syracuse, New York, United States, 13202